home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Unravelled

 
  February, 18 2002 4:05
your information resource in human molecular genetics
 
     
Autosomal dominant polycystic kidney disease (ADPKD) affects 1 in 1000 newborn babies, making it the most common genetic kidney failure disease. ADPKD is due to mutations in either of the PKD1 or the PKD2 genes. PKD2 encodes a calcium channel of the TRP family. In the March issue of Nature Cell Biology (article also published online), Stefan Somlo and his colleagues show that PKD2 functions in epithelial cells of the kidney to release calcium from the endoplasmic reticulum (an intracellular calcium store). In addition, they show that the defect in polycystic kidney disease is loss of this calcium signalling mechanism.

Author contact:

Stefan Somlo
Yale University School of Medicine
New Haven, CT
USA
Tel: +1 203 737 2974
E-mail: stefan.somlo@yale.edu

(C) Nature Cell Biology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.